Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Tjellesen Max Jenne A/S
A/S
Active
CVR 79091812
Ole Lippmanns Vej 2, 2630
Taastrup
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1985 · 41 years old
306 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Tjellesen Max Jenne A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
5.5B
4.2B
2.8B
1.4B
0B
2022: 3.9B
3.9B
2022
2023: 4.2B (+8% vs 2022)
4.2B
+8%
2023
2024: 4.2B (-2% vs 2023)
4.2B
-2%
2024
2025: 4.1B (-1% vs 2024)
4.1B
-1%
2025
2026: 4.4B (+8% vs 2025)
4.4B
+8%
2026
EBITDA
DKK millions
68M
51M
34M
17M
0M
2022: 33M
33M
2022
2023: 25M (-24% vs 2022)
25M
-24%
2023
2024: 27M (+8% vs 2023)
27M
+8%
2024
2025: 28M (+4% vs 2024)
28M
+4%
2025
2026: 55M (+96% vs 2025)
55M
+96%
2026
Income statement
DKK thousands
Item
2026
2025
2024
2023
2022
Revenue
4.448.161
4.133.225
4.172.974
4.238.587
3.909.125
Staff expenses
-115.973
-124.428
-119.249
-122.228
-116.164
EBITDA
55.185
27.739
26.695
25.051
32.532
Depreciation & amort.
-13.768
-14.450
-13.811
-14.094
-14.882
EBIT
41.417
13.289
12.884
10.957
17.650
Net financials
-8.628
-13.158
-10.710
-6.874
-732
Profit before tax
32.789
131
2.174
4.083
16.918
Tax
7.376
182
590
879
3.558
Net profit
25.413
-51
1.584
3.204
13.360
Balance sheet
DKK thousands
Item
2026
2025
2024
2023
2022
Total assets
1.339.077
1.329.680
1.391.269
1.400.498
1.806.974
Equity
496.953
471.540
471.591
470.007
739.803
Long-term debt
0
10.909
10.384
0
0
Short-term debt
838.094
842.072
903.562
925.657
1.062.619
Total debt
838.094
852.981
913.946
925.657
1.062.619
Financial ratios
5-year trend
EBITDA margin
1,2 %
This company
15,8 %
Market median
This company
Market median
92% below market
2022
2026
Equity ratio
37,1 %
This company
38,2 %
Market median
This company
Market median
3% below market
2022
2026
Return on equity
5,1 %
This company
18,4 %
Market median
This company
Market median
72% below market
2022
2026
Net profit margin
0,6 %
This company
8,1 %
Market median
This company
Market median
93% below market
2022
2026
Asset turnover
3,32×
This company
1,12×
Market median
This company
Market median
196% above market
2022
2026
Debt / equity
1,69×
This company
0,62×
Market median
This company
Market median
173% above market
2022
2026
Annual reports & filings
Annual report 2026
Filed via CVR / Virk · Period 2025-04-01 – 2026-03-31
View
PDF
Annual report 2025
Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
View
PDF
More on Tjellesen Max Jenne A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
